SCHEMBL101744

SCHEMBL101744

O=S1(=O)CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexane SCHEMBL28106489 1.00
SCHEMBL17515336 1.00
SCHEMBL1381471 1.00
SCHEMBL256059 1.00
SCHEMBL9623859 1.00
SCHEMBL9623601 1.00
SCHEMBL9623851 1.00
SCHEMBL867332 1.00
SCHEMBL20549279 1.00
Water SCHEMBL7201564 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4567 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637455-B2 Naphthyridine and pyrido[3,4-c]pyridazine derivatives as GABAA α5 receptor modulators RICHTER GEDEON NYRT. (HU) 2026-05-26 US claimed
US-20260109709-A1 2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS MIRATI THERAPEUTICS INC (US) 2026-04-23 US claimed
US-20260070897-A1 INDAZOLE COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION UNIV VANDERBILT (US) 2026-03-12 US claimed
EP-3623372-B1 PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS VALO HEALTH INC (US) 2026-02-04 EP claimed
US-20250388567-A1 SELECTIVE G PROTEIN-COUPLED RECEPTOR KINASE 5 INHIBITORS, COMPOSITIONS, AND METHODS OF USE PURDUE RESEARCH FOUNDATION (US) 2025-12-25 US claimed
US-20250376469-A1 INDOLIZINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-12-11 US claimed
US-20250376468-A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-12-11 US claimed
EP-3856342-B1 BICYCLIC DERIVATIVES AS GABAA A5 RECEPTOR MODULATORS RICHTER GEDEON NYRT (HU) 2025-12-10 EP claimed
US-12404295-B2 (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives IDORSIA PHARMACEUTICALS LTD (CH) 2025-09-02 US claimed
US-12344600-B2 c-Myc mRNA translation modulators and uses thereof in the treatment of cancer ANIMA BIOTECH INC. (US) 2025-07-01 US claimed
CN-1046296-C Process for polymerization of cyclic olefins and polymerizable composition CIBA GEIGY AG (CH) 1999-11-10 CN claimed
US-5854299-A Process for the polymerization of cyclic olefins and polymerizable composition CIBA SPECIALTY CHEMICALS CORPORATION (US) 1998-12-29 US claimed
CN-1130388-A Process for polymerizing cycloolefins and polymerizable composition CIBA GEIGY AG (CH) 1996-09-04 CN claimed
EP-0722468-A1 PROCESS FOR THE POLYMERIZATION OF CYCLIC OLEFINS AND A POLYMERIZABLE COMPOSITION Ciba SC Holding AG (CH) 1996-07-24 EP claimed
US-5476743-A Thermoplastic resin, a charge director, a liquid component, an additive selected from cyclic carbonates, cyclic sulfones, cyclic sulfoxides and organic amides, pigments, and a charge adjuvant XEROX CORPORATION (US) 1995-12-19 US claimed
WO-1995007310-A1 PROCESS FOR THE POLYMERIZATION OF CYCLIC OLEFINS AND A POLYMERIZABLE COMPOSITION CIBA-GEIGY AG (CH) 1995-03-16 WO claimed
US-5081275-A Process for the preparation of 2-fluorobenzonitrile from saccharin ALLIED-SIGNAL INC. (US) 1992-01-14 US claimed
US-4680412-A Preparation of fluorophthalimides BASF AKTIENGESELLSCHAFT (DE) 1987-07-14 US claimed
US-3966727-A Manufacture of phthalo-bis-guanamines BASF AKTIENGESELLSCHAFT (DT) 1976-06-29 US claimed
US-3933866-A Process for the manufacture of amino-anthraquinones CIBA-GEIGY AG (CH) 1976-01-20 US claimed